REG - OptiBiotix Health - Result of AGM <Origin Href="QuoteRef">OPTIO.L</Origin>

OptiBiotix HealthAnnouncement

11/08/2015 12:22

RNS Number : 7290V
OptiBiotix Health PLC
11 August 2015
11 August 2015
OptiBiotix Health plc
("OptiBiotix"orthe Company")
Result of AGM
OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol and diabetes announces that at the Annual General Meeting held earlier today, all resolutions were duly passed.
OptiBiotix Health plc
www.optibiotix.com
Stephen O'Hara, Chief Executive
Contact via Walbrook below


Cairn Financial Advisers LLP

Liam Murray / Avi Robinson
Tel: 020 7148 7900


Hybridan LLP (Joint Broker)

Claire Louise Noyce
Tel: 020 3764 2341


Peterhouse Corporate Finance Ltd (Joint Broker)

Lucy Williams / Duncan Vasey
Tel: 020 7469 0936


Walbrook PR Ltd
Tel: 020 7933 8780 or optibiotix@walbrookpr.com
Anna Dunphy
Mob: 07876 741 001
Mike Wort
Mob: 07900 608 002
About OptiBiotix Health PLC - www.optibiotix.com 
OptiBiotix was formed in March 2012 to develop compounds which modify the human microbiome - the collective genome of the microbes in the body - to prevent and manage human disease. 
The aim of OptiBiotix is to discover and develop microbial strains, compounds and formulations, which modulate the human microbiome and can be used as food ingredients and supplements or active compounds for the prevention and management of human metabolic diseases, examples of which include obesity, cholesterol and lipid distribution and diabetes. 
OptiBiotix has established a pipeline of microbiome modulators that can impact on lipid and cholesterol management, energy harvest and appetite suppression. The development pipeline is fuelled by its proprietary OptiScreen and OptiBiotic platform technologies designed to identify metabolic pathways and compounds that impact on human physiology and bring potential health benefits. These platforms are applicable across a wider range of other human diseases. 

This information is provided by RNS
The company news service from the London Stock Exchange
  END
RAGPBMBTMBMBBFA